This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Menu
Book
Next Generation CAR & T Cell Therapies 2021 Agendakeyboard_arrow_right

Next Generation CAR & T Cell Therapies 2021 Agenda

keyboard_arrow_leftSearch & Filter
search

Next Generation CAR & T Cell Therapies 2021 Agenda

search
Next Generation CAR & T Cell Therapies 2021 Agenda 9:45am - 9:50am5 mins
CONFERENCE DAY ONE - June 22nd
Opening Remarks from Sarah Lintern, Conference Director
    Next Generation CAR & T Cell Therapies 2021 Agenda 9:50am - 10:00am10 mins
    CONFERENCE DAY ONE - June 22nd
    Conference Opening and Welcome
      Next Generation CAR & T Cell Therapies 2021 Agenda 9:50am - 10:00am10 mins
      CONFERENCE DAY TWO - June 23rd
      Conference Opening and Welcome
        Next Generation CAR & T Cell Therapies 2021 Agenda 9:50am - 10:00am10 mins
        CONFERENCE THREE - June 24th
        Conference Opening and Welcome
          Next Generation CAR & T Cell Therapies 2021 Agenda 10:05am - 10:25am20 mins
          CONFERENCE DAY ONE - June 22nd
          Preclinical CAR T Discovery Candidate Selection for Targets such as CD70 Or DLL3
          • Siler Panowski - Director of Biology, Solid Tumors, Allogene, USA
          Next Generation CAR & T Cell Therapies 2021 Agenda 10:05am - 10:25am20 mins
          CONFERENCE DAY TWO - June 23rd
          Harnessing of Blood Derived Gamma Delta T Cells for Cancer Immunotherapy
          • John Maher - CSO, Leucid Bio, Clinical Senior Lecturer in Immunology, Kings College London
          Next Generation CAR & T Cell Therapies 2021 Agenda 10:05am - 10:25am20 mins
          CONFERENCE THREE - June 24th
          Translational Lessons from Pivotal Axi-Cel Trial (ZUMA-1): Implications for Safety, Efficacy and Next Generation Products
          • Simone Filosto - Principal Scientist I, Cell Biology, Kite Pharma
          Next Generation CAR & T Cell Therapies 2021 Agenda 10:30am - 10:50am20 mins
          CONFERENCE DAY ONE - June 22nd
          Creating a Feedback Loop Between Clinical Trials and Translational Science for Product Improvement
            Next Generation CAR & T Cell Therapies 2021 Agenda 10:30am - 10:50am20 mins
            CONFERENCE DAY TWO - June 23rd
            Clinical Development with Two Distinct Proprietary and Unique Non-Gene Edited Allogeneic Technology Approaches
            • Frédéric F. Lehmann - Head Global Clinical Development and Medical Affairs, Vice President, Celyad, Belgium
            Next Generation CAR & T Cell Therapies 2021 Agenda 10:30am - 10:50am20 mins
            CONFERENCE THREE - June 24th
            Contextual Secretion of Nanoscale, Antigen-Dependent IL-12 By CAR T Cells for Cancer Treatment
            • Zhifen Yang - Associate Director, Refuge Biotech
            Next Generation CAR & T Cell Therapies 2021 Agenda 10:55am - 11:15am20 mins
            CONFERENCE DAY ONE - June 22nd
            Spotlight Presentation
              Next Generation CAR & T Cell Therapies 2021 Agenda 10:55am - 11:15am20 mins
              CONFERENCE DAY TWO - June 23rd
              PANEL: Next Generation CAR Strategies – Allo, NK and Macrophages for Treating Multiple Patients
              • John Tomtishen - Director of Manufacturing, Technical Operations, Legend Biotech Co., USA
              • John Maher - CSO, Leucid Bio, Clinical Senior Lecturer in Immunology, Kings College London
              • Frédéric F. Lehmann - Head Global Clinical Development and Medical Affairs, Vice President, Celyad, Belgium
              • Dan MacLeod - Senior Director, Cell Therapy Discovery, Precision BioSciences, Inc., USA
              Next Generation CAR & T Cell Therapies 2021 Agenda 10:55am - 11:15am20 mins
              CONFERENCE THREE - June 24th
              Spotlight Presentation
                Next Generation CAR & T Cell Therapies 2021 Agenda 11:15am - 11:35am20 mins
                CONFERENCE DAY ONE - June 22nd
                Speaker Q&A
                  Next Generation CAR & T Cell Therapies 2021 Agenda 11:15am - 11:35am20 mins
                  CONFERENCE DAY TWO - June 23rd
                  Speaker Q&A
                    Next Generation CAR & T Cell Therapies 2021 Agenda 11:15am - 11:35am20 mins
                    CONFERENCE THREE - June 24th
                    Speaker Q&A
                      Next Generation CAR & T Cell Therapies 2021 Agenda 11:35am - 12:00pm25 mins
                      CONFERENCE DAY ONE - June 22nd
                      Morning Coffee and Networking
                        Next Generation CAR & T Cell Therapies 2021 Agenda 11:35am - 12:00pm25 mins
                        CONFERENCE DAY TWO - June 23rd
                        Morning Coffee and Networking
                          Next Generation CAR & T Cell Therapies 2021 Agenda 11:35am - 12:00pm25 mins
                          CONFERENCE THREE - June 24th
                          Morning Coffee and Networking
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:00pm - 12:20pm20 mins
                            CONFERENCE DAY ONE - June 22nd
                            In vivo engineering of CAR-T cells: A promising new approach to cancer immunotherapy
                            • Shon Green - Senior Director, Translational Sciences, Umoja Biopharma
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:00pm - 12:20pm20 mins
                            CONFERENCE DAY TWO - June 23rd
                            Driving lupus out with CARs
                            • Marko Radic - Associate Professor, Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:00pm - 12:20pm20 mins
                            CONFERENCE THREE - June 24th
                            Fusion Proteins to Bridge CAR19 T Cell and Tumor Cells
                            • Paul Rennert - President & CSO, Aleta BioTherapeutics
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:25pm - 12:45pm20 mins
                            CONFERENCE DAY ONE - June 22nd
                            CAR-T therapy for solid tumors: The Road Ahead
                            • Shipra Das - Team Leader Immuno-Oncology, Cellectis
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:25pm - 12:45pm20 mins
                            CONFERENCE DAY TWO - June 23rd
                            Clinical Case Study – Novel CARs & TCRs
                            • Paul Lammers - President & CEO, Triumvira Immunologics
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:25pm - 12:45pm20 mins
                            CONFERENCE THREE - June 24th
                            DAP10/12 co-stimulation/Signaling Domains & HuLym-1 CAR T-cells Targeting HLA-DR Expressed by Lymphomas and Most Solid Tumors
                            • Alan Epstein - Professor of Pathology, Keck School of Medicine of USC, USA
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:50pm - 1:10pm20 mins
                            CONFERENCE DAY ONE - June 22nd
                            Targeted CART Approaches for Solid Tumours
                            • Astero Klampatsa - Team Leader, Institute of Cancer Research
                            Next Generation CAR & T Cell Therapies 2021 Agenda 12:50pm - 1:10pm20 mins
                            CONFERENCE DAY TWO - June 23rd
                            Spotlight Presentation
                              Next Generation CAR & T Cell Therapies 2021 Agenda 12:50pm - 1:10pm20 mins
                              CONFERENCE THREE - June 24th
                              Spotlight Presentation
                                Next Generation CAR & T Cell Therapies 2021 Agenda 1:10pm - 1:30pm20 mins
                                CONFERENCE DAY ONE - June 22nd
                                Speaker Q&A
                                  Next Generation CAR & T Cell Therapies 2021 Agenda 1:10pm - 1:30pm20 mins
                                  CONFERENCE DAY TWO - June 23rd
                                  Speaker Q&A
                                    Next Generation CAR & T Cell Therapies 2021 Agenda 1:10pm - 1:30pm20 mins
                                    CONFERENCE THREE - June 24th
                                    Speaker Q&A
                                      Next Generation CAR & T Cell Therapies 2021 Agenda 1:30pm - 2:15pm45 mins
                                      CONFERENCE DAY ONE - June 22nd
                                      Sponsored Luncheon Presentations
                                        Next Generation CAR & T Cell Therapies 2021 Agenda 1:30pm - 2:15pm45 mins
                                        CONFERENCE DAY TWO - June 23rd
                                        Sponsored Luncheon Presentations
                                          Next Generation CAR & T Cell Therapies 2021 Agenda 1:30pm - 2:15pm45 mins
                                          CONFERENCE THREE - June 24th
                                          Sponsored Luncheon Presentations
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 2:15pm - 2:35pm20 mins
                                            CONFERENCE DAY ONE - June 22nd
                                            Switchable CAR-T for Solid Tumours
                                            • Travis Young - VP, Biologics, Calibr at Scripps Research, USA
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 2:15pm - 2:35pm20 mins
                                            CONFERENCE DAY TWO - June 23rd
                                            CAR Macrophage Case Study
                                            • Michael Klichinsky - Co-Founder, Carisma Therapeutics
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 2:15pm - 2:35pm20 mins
                                            CONFERENCE THREE - June 24th
                                            Centralized vs. Decentralized Patient Treatment Approaches
                                            • Allison Matthews - Senior Service Designer, Innovation and Design, Mayo Clinic
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 2:40pm - 3:00pm20 mins
                                            CONFERENCE DAY ONE - June 22nd
                                            Solid Tumour Targeted CAR’s with Armor Tailored for Solid Tumour Microenvironments
                                            • Blake Aftab - Vice President, Research, Atara Biotherapeutics
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 2:40pm - 3:00pm20 mins
                                            CONFERENCE DAY TWO - June 23rd
                                            Predictive Biomarkers of Response and Toxicity to Anti-CD19 CAR T Cell Therapy
                                            • Rhine Shen - Principal Scientist, Kite, a Gilead Company, USA
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 2:40pm - 3:00pm20 mins
                                            CONFERENCE THREE - June 24th
                                            Progress in Manufacturing of Lentiviral Vectors in Suspension Systems
                                            • David Hsu - Senior Director, City of Hope
                                            Next Generation CAR & T Cell Therapies 2021 Agenda 3:00pm - 3:20pm20 mins
                                            CONFERENCE THREE - June 24th
                                            Speaker Q&A
                                              Next Generation CAR & T Cell Therapies 2021 Agenda 3:05pm - 3:25pm20 mins
                                              CONFERENCE DAY ONE - June 22nd
                                              3T Case Study - Identification of Novel Targets for the Treatment of Solid Tumours in Broad Patient Populations
                                              • Hanspeter Gerber - CSO & SVP, 3T Biosciences
                                              Next Generation CAR & T Cell Therapies 2021 Agenda 3:05pm - 3:25pm20 mins
                                              CONFERENCE DAY TWO - June 23rd
                                              CRISPR Screens for Finding New or Selecting T Cell Edits for Different Solid Tumours
                                              • Birgit Schultes - Vice President, Immunology (Cell Therapies), Intellia Therapeutics, USA
                                              Next Generation CAR & T Cell Therapies 2021 Agenda 3:20pm - 3:25pm5 mins
                                              CONFERENCE THREE - June 24th
                                              End of Day Three
                                                Next Generation CAR & T Cell Therapies 2021 Agenda 3:30pm - 3:50pm20 mins
                                                CONFERENCE DAY ONE - June 22nd
                                                TCR Identification in Solid Tumour Indications
                                                • Felix Lorenz - Head of Captain T Cell, Max-Delbrück-Center for Molecular Medicine (MDC Berlin), Germany
                                                Next Generation CAR & T Cell Therapies 2021 Agenda 3:30pm - 3:50pm20 mins
                                                CONFERENCE DAY TWO - June 23rd
                                                Spotlight Presentation
                                                  Next Generation CAR & T Cell Therapies 2021 Agenda 3:50pm - 4:10pm20 mins
                                                  CONFERENCE DAY ONE - June 22nd
                                                  Speaker Q&A
                                                    Next Generation CAR & T Cell Therapies 2021 Agenda 3:50pm - 4:10pm20 mins
                                                    CONFERENCE DAY TWO - June 23rd
                                                    Speaker Q&A
                                                      Next Generation CAR & T Cell Therapies 2021 Agenda 4:10pm - 4:15pm5 mins
                                                      CONFERENCE DAY ONE - June 22nd
                                                      End of Day One
                                                        Next Generation CAR & T Cell Therapies 2021 Agenda 4:10pm - 4:15pm5 mins
                                                        CONFERENCE DAY TWO - June 23rd
                                                        End of Day Two
                                                          Filter
                                                          Streams
                                                          Formats
                                                          Choose Day